Atlas Trials

Rasburicase in Tumor Lysis Syndrome

Clinical trial NCT00302653 · COMPLETED

Trial details

NCT number
NCT00302653
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hyperuricemia
Start date
2006-02-01
Primary completion
2006-11-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.